caudatin and Glioblastoma

caudatin has been researched along with Glioblastoma* in 1 studies

Other Studies

1 other study(ies) available for caudatin and Glioblastoma

ArticleYear
Chinese herb related molecules Catechins, Caudatin and Cucurbitacin-I inhibit the proliferation of glioblastoma by activating KDELR2-mediated endoplasmic reticulum stress.
    Biochemical and biophysical research communications, 2023, Dec-20, Volume: 687

    Brain gliomas are difficult in the field of tumor therapy because of their high recurrence rate, high mortality rate, and low selectivity of therapeutic agents. The efficacy of Traditional Chinese Medicine (TCM) in the treatment for tumours has been widely recognized. Here, three Chinese herb related molecules, namely Catechins, Caudatin and Cucurbitacin-I, were screened by bioinformatic means, and were found to inhibit the proliferation of glioblastoma T98G cells using Colony-forming and CCK-8 assays. Notably, the simultaneous use of all three molecules could more significantly inhibit the proliferation of glioma cells. Consistent with this, temozolomide, each in the combination with three molecules, could synergistically inhibit the proliferation of T98G cells. Results of qPCR assay was also showed that this inhibition was through the activation of the KDELR2-mediated endoplasmic reticulum stress (ER) pathway. Molecular docking experiments further revealed that Catechins, Caudatin and Cucurbitacin-I could activate ER stress might by targeting KDELR2. Taken together, these results suggest that these herbal molecules have the potential to inhibit the growth of glioma cells and could provide a reference for clinical therapeutic drug selection.

    Topics: Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cucurbitacins; Endoplasmic Reticulum Stress; Glioblastoma; Glioma; Humans; Molecular Docking Simulation; Vesicular Transport Proteins

2023